Santosā plan to reach net zero greenhouse gas emissions by 2040 was ālittle more than a series of speculationsā, a shareholder group has said on the first day of trial in a landmark greenwashing case.
S&P is free to pay for a Rolls-Royce defence in “Rolls-Royce litigation” that alleges the agency engaged in fraud in assigning ratings to risky financial products, a judge has said.
Clive Palmer’s nephew has applied to the High Court for review of a decision rejecting his bid to dodge contempt proceedings, arguing he did not submit to the court’s jurisdiction.
The funder bankrolling a class action by residents allegedly displaced by the construction of the $16.8 billion WestConnex tunnel has abandoned the case.
A class action targeting Westpac subsidiary BT Funds and Tal Life Insurance was discontinued after documents discovered by the companies caused funder Woodsford to bow out.
A ‘junk’ insurance class action against Suncorp unit AAI wants an initial trial to deal with the claim — absent a sample group member — that car dealers made purchasing a policy necessary for a loan.
Green iron start-up Element Zero is continuing its fight over search orders won by rival Fortescue that it claimed were a massive over-reach.
Expert evidence is not meant to āprovide a judge with comfortā, a judge has found in rejecting evidence from two experts in flex commissions class actions against Westpac and Macquarie.
The scope of protection for geographical indications will be at issue in India’s appeal of a decision that barred it from registering a trade mark for basmati rice.
Bayer has lost its battle to protect top-selling blood thinner Xarelto from generic competition, with the Full Court finding two patents for the drug are invalid.